79 related articles for article (PubMed ID: 17638921)
1. Selenium status alters tumour differentiation but not incidence or latency of pancreatic adenocarcinomas in Ela-TGF-alpha p53+/ mice.
Aichler M; Algül H; Behne D; Hölzlwimmer G; Michalke B; Quintanilla-Martinez L; Schmidt J; Schmid RM; Brielmeier M
Carcinogenesis; 2007 Sep; 28(9):2002-7. PubMed ID: 17638921
[TBL] [Abstract][Full Text] [Related]
2. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF
Cancer Res; 2006 Jan; 66(1):508-16. PubMed ID: 16397267
[TBL] [Abstract][Full Text] [Related]
3. Pattern of secondary genomic changes in pancreatic tumors of Tgf alpha/Trp53+/- transgenic mice.
Schreiner B; Baur DM; Fingerle AA; Zechner U; Greten FR; Adler G; Sipos B; Klöppel G; Hameister H; Schmid RM
Genes Chromosomes Cancer; 2003 Nov; 38(3):240-8. PubMed ID: 14506698
[TBL] [Abstract][Full Text] [Related]
4. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
5. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.
Hermanova M; Trna J; Nenutil R; Dite P; Kala Z
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):732-9. PubMed ID: 18617777
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
7. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
8. [New molecular targets in pancreatic cancer].
Torrisani J; Bournet B; Cordelier P; Buscail L
Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
[TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of selenium-depleted and selenium-supplemented mice.
Hooven LA; Butler J; Ream LW; Whanger PD
Biol Trace Elem Res; 2006 Feb; 109(2):173-79. PubMed ID: 16444006
[TBL] [Abstract][Full Text] [Related]
10. Fundamental differences in the neural invasion behavior of pancreatic endocrine tumors: relevance for local recurrence rates?
Bergmann F; Ceyhan GO; Rieker RJ; Esposito I; Fischer L; Herpel E; Friess H; Schirmacher P; Kern MA
Hum Pathol; 2009 Jan; 40(1):50-7. PubMed ID: 18789481
[TBL] [Abstract][Full Text] [Related]
11. Effect of nicotine and cigarette smoke on an experimental model of intraepithelial lesions and pancreatic adenocarcinoma induced by 7,12-dimethylbenzanthracene in mice.
Bersch VP; Osvaldt AB; Edelweiss MI; Schumacher Rde C; Wendt LR; Abreu LP; Blom CB; Abreu GP; Costa L; Piccinini P; Rohde L
Pancreas; 2009 Jan; 38(1):65-70. PubMed ID: 18824948
[TBL] [Abstract][Full Text] [Related]
12. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.
Siveke JT; Einwächter H; Sipos B; Lubeseder-Martellato C; Klöppel G; Schmid RM
Cancer Cell; 2007 Sep; 12(3):266-79. PubMed ID: 17785207
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
14. Effect of dietary selenium on tumor induction by an oncogenic virus.
Exon JH; Koller LD; Elliott SC
Clin Toxicol; 1976; 9(2):273-9. PubMed ID: 939079
[TBL] [Abstract][Full Text] [Related]
15. Effects of selenium and low levels of lead on mammary tumor development and growth in MMTV-infected female mice.
Schrauzer GN
Biol Trace Elem Res; 2008 Dec; 125(3):268-75. PubMed ID: 18726561
[TBL] [Abstract][Full Text] [Related]
16. Effects of selenium diet on expression of selenoproteins in the lung of the rat.
Bukalis K; Alber D; Bukalis G; Behne D; Kyriakopoulos A
Ann N Y Acad Sci; 2007 Jan; 1095():467-72. PubMed ID: 17404059
[TBL] [Abstract][Full Text] [Related]
17. [Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3].
Xu J; Liu C; Yu XJ; Jin C; Fu DL; Ni QX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1948-51. PubMed ID: 19062732
[TBL] [Abstract][Full Text] [Related]
18. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
[TBL] [Abstract][Full Text] [Related]
19. Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice.
Kiermayer C; Michalke B; Schmidt J; Brielmeier M
Biol Chem; 2007 Oct; 388(10):1091-7. PubMed ID: 17937623
[TBL] [Abstract][Full Text] [Related]
20. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.
Cano CE; Gommeaux J; Pietri S; Culcasi M; Garcia S; Seux M; Barelier S; Vasseur S; Spoto RP; Pébusque MJ; Dusetti NJ; Iovanna JL; Carrier A
Cancer Res; 2009 Jan; 69(1):219-26. PubMed ID: 19118006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
